Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT
Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) mutations have uncertain prognostic implications in AML. We investigate the impact IDH1 and IDH2 mutations in AML patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) in first complete remission (CR1). In total, 1515 adult pati...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
14 August 2024
|
| In: |
Bone marrow transplantation
Year: 2024, Volume: 59, Issue: 11, Pages: 1534-1541 |
| ISSN: | 1476-5365 |
| DOI: | 10.1038/s41409-024-02384-2 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41409-024-02384-2 Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41409-024-02384-2 
|
| Author Notes: | Razan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin, Jordi Esteve, Nicolaus Kröger, Jan J. Cornelissen, Didier Blaise, Gerard Socié, Sébastien Maury, Arnold Ganser, Tobias Gedde-Dahl, Peter von dem Borne, Jean Henri Bourhis, Claude Eric Bulabois, Ibrahim Yakoub-Agha, Caroline Pabst, Stéphanie Nguyen, Patrice Chevallier, Anne Huynh, Ali Bazarbachi, Arnon Nagler, Fabio Ciceri and Mohamad Mohty |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1928948847 | ||
| 003 | DE-627 | ||
| 005 | 20250710231441.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250624s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41409-024-02384-2 |2 doi | |
| 035 | |a (DE-627)1928948847 | ||
| 035 | |a (DE-599)KXP1928948847 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Mohty, Razan |e VerfasserIn |0 (DE-588)1369539347 |0 (DE-627)1928951538 |4 aut | |
| 245 | 1 | 0 | |a Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation |b a study of the ALWP of the EBMT |c Razan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin, Jordi Esteve, Nicolaus Kröger, Jan J. Cornelissen, Didier Blaise, Gerard Socié, Sébastien Maury, Arnold Ganser, Tobias Gedde-Dahl, Peter von dem Borne, Jean Henri Bourhis, Claude Eric Bulabois, Ibrahim Yakoub-Agha, Caroline Pabst, Stéphanie Nguyen, Patrice Chevallier, Anne Huynh, Ali Bazarbachi, Arnon Nagler, Fabio Ciceri and Mohamad Mohty |
| 246 | 3 | 3 | |a Isocitrate dehydrogenase (IDH) one and two mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation |
| 264 | 1 | |c 14 August 2024 | |
| 300 | |b Diagramme | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.06.2025 | ||
| 520 | |a Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) mutations have uncertain prognostic implications in AML. We investigate the impact IDH1 and IDH2 mutations in AML patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) in first complete remission (CR1). In total, 1515 adult patients were included, 15.91% (n = 241) carried IDH1 mutation (mIDH1), and 26.27% (n = 398) IDH2 mutation (mIDH2) and 57.82% (n = 876) had no-IDH mutation. NPM1 was frequently encountered with IDH1 mutation (no-IDH group, n = 217, 24.8%, mIDH1, n = 103, 42.7%, mIDH2, n = 111, 27.9%, p < 0.0001). At day 180, the cumulative incidence (CI) of grade II-IV acute graft-versus-host disease (GVHD) was significantly lower in mIDH1 and mIDH2 compared to no-IDH groups (Hazard ratio [HR] = 0.66 (95% CI 0.47-0.91), p = 0.011; HR = 0.73 (95% CI 0.56-0.96), p = 0.025, respectively). In the mIDH1 group, overall survival (OS) was improved compared to no-IDH (HR = 0.68 (95% CI 0.48-0.94), p = 0.021), whereas mIDH2 was associated with lower incidence of relapse (HR = 0.49 (95% CI 0.34-0.7), p < 0.001), improved leukemia free survival (LFS) (HR = 0.7 (95% CI 0.55-0.9), p = 0.004) and OS (HR = 0.74 (95% CI 0.56-0.97), p = 0.027). In the subgroup of NPM1 wild type, only IDH2 was associated with improved outcomes. In conclusion, our data suggest that IDH1 and IDH2 mutations are associated with improved outcomes in patients with AML undergoing allo-HCT in CR1. | ||
| 650 | 4 | |a Acute myeloid leukaemia | |
| 650 | 4 | |a Haematopoietic stem cells | |
| 650 | 4 | |a Stem-cell research | |
| 700 | 1 | |a Bazarbachi, Abdul Hamid |e VerfasserIn |4 aut | |
| 700 | 1 | |a Labopin, Myriam |e VerfasserIn |4 aut | |
| 700 | 1 | |a Esteve, Jordi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kröger, Nicolaus |d 1959- |e VerfasserIn |0 (DE-588)112156533 |0 (DE-627)477107354 |0 (DE-576)167115103 |4 aut | |
| 700 | 1 | |a Cornelissen, Jan J. |e VerfasserIn |4 aut | |
| 700 | 1 | |8 1\p |a Blaise, Didier |d 1955- |e VerfasserIn |0 (DE-588)1261106237 |0 (DE-627)1834173612 |4 aut | |
| 700 | 1 | |a Socié, Gerard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Maury, Sébastien |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ganser, Arnold |d 1954- |e VerfasserIn |0 (DE-588)133814300 |0 (DE-627)556252268 |0 (DE-576)300124171 |4 aut | |
| 700 | 1 | |a Gedde-Dahl, Tobias |e VerfasserIn |4 aut | |
| 700 | 1 | |a von dem Borne, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bourhis, Jean-Henri |e VerfasserIn |0 (DE-588)1250046874 |0 (DE-627)1786940779 |4 aut | |
| 700 | 1 | |a Bulabois, Claude Eric |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yakoub-Agha, Ibrahim |e VerfasserIn |0 (DE-588)1017074054 |0 (DE-627)690277938 |0 (DE-576)353090204 |4 aut | |
| 700 | 1 | |a Pabst, Caroline |d 1981- |e VerfasserIn |0 (DE-588)136164668 |0 (DE-627)577203819 |0 (DE-576)284653667 |4 aut | |
| 700 | 1 | |a Nguyen, Stéphanie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chevallier, Patrice |e VerfasserIn |4 aut | |
| 700 | 1 | |a Huynh, Anne |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bazarbachi, Ali |e VerfasserIn |0 (DE-588)1189768747 |0 (DE-627)1668480697 |4 aut | |
| 700 | 1 | |a Nagler, Arnon |e VerfasserIn |0 (DE-588)142491268 |0 (DE-627)636708764 |0 (DE-576)331009021 |4 aut | |
| 700 | 1 | |a Ciceri, Fabio |e VerfasserIn |0 (DE-588)1260305732 |0 (DE-627)1922854816 |4 aut | |
| 700 | 1 | |a Mohty, Mohamad |e VerfasserIn |0 (DE-588)120428041X |0 (DE-627)1689623160 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bone marrow transplantation |d London : Springer Nature, 1997 |g 59(2024), 11, Seite 1534-1541 |h Online-Ressource |w (DE-627)320433366 |w (DE-600)2004030-1 |w (DE-576)091012996 |x 1476-5365 |7 nnas |a Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation a study of the ALWP of the EBMT |
| 773 | 1 | 8 | |g volume:59 |g year:2024 |g number:11 |g pages:1534-1541 |g extent:8 |a Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation a study of the ALWP of the EBMT |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41409-024-02384-2 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41409-024-02384-2 |x Verlag |z kostenfrei |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20250624 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 136164668 |a Pabst, Caroline |m 136164668:Pabst, Caroline |d 910000 |d 910100 |e 910000PP136164668 |e 910100PP136164668 |k 0/910000/ |k 1/910000/910100/ |p 16 | ||
| 999 | |a KXP-PPN1928948847 |e 4737958875 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"14 August 2024"}],"title":[{"subtitle":"a study of the ALWP of the EBMT","title":"Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation","title_sort":"Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation"}],"person":[{"display":"Mohty, Razan","family":"Mohty","given":"Razan","role":"aut"},{"given":"Abdul Hamid","family":"Bazarbachi","display":"Bazarbachi, Abdul Hamid","role":"aut"},{"family":"Labopin","display":"Labopin, Myriam","given":"Myriam","role":"aut"},{"family":"Esteve","display":"Esteve, Jordi","given":"Jordi","role":"aut"},{"role":"aut","given":"Nicolaus","family":"Kröger","display":"Kröger, Nicolaus"},{"given":"Jan J.","family":"Cornelissen","display":"Cornelissen, Jan J.","role":"aut"},{"role":"aut","given":"Didier","display":"Blaise, Didier","family":"Blaise"},{"family":"Socié","display":"Socié, Gerard","given":"Gerard","role":"aut"},{"role":"aut","given":"Sébastien","family":"Maury","display":"Maury, Sébastien"},{"family":"Ganser","display":"Ganser, Arnold","given":"Arnold","role":"aut"},{"given":"Tobias","display":"Gedde-Dahl, Tobias","family":"Gedde-Dahl","role":"aut"},{"role":"aut","family":"von dem Borne","display":"von dem Borne, Peter","given":"Peter"},{"role":"aut","display":"Bourhis, Jean-Henri","family":"Bourhis","given":"Jean-Henri"},{"role":"aut","display":"Bulabois, Claude Eric","family":"Bulabois","given":"Claude Eric"},{"role":"aut","display":"Yakoub-Agha, Ibrahim","family":"Yakoub-Agha","given":"Ibrahim"},{"given":"Caroline","display":"Pabst, Caroline","family":"Pabst","role":"aut"},{"role":"aut","given":"Stéphanie","family":"Nguyen","display":"Nguyen, Stéphanie"},{"role":"aut","given":"Patrice","family":"Chevallier","display":"Chevallier, Patrice"},{"family":"Huynh","display":"Huynh, Anne","given":"Anne","role":"aut"},{"family":"Bazarbachi","display":"Bazarbachi, Ali","given":"Ali","role":"aut"},{"given":"Arnon","family":"Nagler","display":"Nagler, Arnon","role":"aut"},{"given":"Fabio","display":"Ciceri, Fabio","family":"Ciceri","role":"aut"},{"given":"Mohamad","family":"Mohty","display":"Mohty, Mohamad","role":"aut"}],"titleAlt":[{"title":"Isocitrate dehydrogenase (IDH) one and two mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation"}],"physDesc":[{"noteIll":"Diagramme","extent":"8 S."}],"recId":"1928948847","note":["Gesehen am 24.06.2025"],"name":{"displayForm":["Razan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin, Jordi Esteve, Nicolaus Kröger, Jan J. Cornelissen, Didier Blaise, Gerard Socié, Sébastien Maury, Arnold Ganser, Tobias Gedde-Dahl, Peter von dem Borne, Jean Henri Bourhis, Claude Eric Bulabois, Ibrahim Yakoub-Agha, Caroline Pabst, Stéphanie Nguyen, Patrice Chevallier, Anne Huynh, Ali Bazarbachi, Arnon Nagler, Fabio Ciceri and Mohamad Mohty"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1928948847"],"doi":["10.1038/s41409-024-02384-2"]},"language":["eng"],"relHost":[{"disp":"Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation a study of the ALWP of the EBMTBone marrow transplantation","pubHistory":["Nachgewiesen 19.1997 -"],"recId":"320433366","note":["Gesehen am 17.01.25"],"language":["eng"],"id":{"eki":["320433366"],"issn":["1476-5365"],"zdb":["2004030-1"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"1997","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group","dateIssuedDisp":"1997-","publisherPlace":"London ; Basingstoke ; London"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Bone marrow transplantation","title_sort":"Bone marrow transplantation"}],"part":{"text":"59(2024), 11, Seite 1534-1541","pages":"1534-1541","volume":"59","issue":"11","extent":"8","year":"2024"}}]} | ||
| SRT | |a MOHTYRAZANISOCITRATE1420 | ||